UNII:C19D0413EL
Names
[ CAS No. ]:
56392-16-6
[ Name ]:
UNII:C19D0413EL
[Synonym ]:
1-[4-(1-Hydroxy-2-methoxyethyl)phenoxy]-3-(isopropylamino)-2-propanol
3-[4-(1-Hydroxy-2-methoxyethyl)phenoxy]-1-isopropylamino-2-propanol
Benzenemethanol, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-α-(methoxymethyl)-
α-HYDROXYMETOPROLOL
1-[4-(1-hydroxy-2-methoxyethyl)phenoxy]-3-(isopropylamino)propan-2-ol
UNII:C19D0413EL
Biological Activity
[Description]:
[Related Catalog]:
[References]
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
437.6±45.0 °C at 760 mmHg
[ Melting Point ]:
65-67ºC
[ Molecular Formula ]:
C15H25NO4
[ Molecular Weight ]:
283.363
[ Flash Point ]:
218.4±28.7 °C
[ Exact Mass ]:
283.178345
[ PSA ]:
70.95000
[ LogP ]:
0.72
[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C
[ Index of Refraction ]:
1.524
[ Storage condition ]:
-20°C Freezer
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- DA4907000
- CHEMICAL NAME :
- Benzenemethanol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-alpha-( methoxymethyl)-
- CAS REGISTRY NUMBER :
- 56392-16-6
- LAST UPDATED :
- 198809
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C15-H25-N-O4
- MOLECULAR WEIGHT :
- 283.41
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 2,186,1979
Safety Information
[ RIDADR ]:
NONH for all modes of transport
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
Bioanalysis 4(23) , 2781-93, (2012)
Metoprolol (MET) is a β1-adrenoceptor antagonist, which is widely used in the treatment of cardiovascular diseases, and α-hydroxymetoprolol (α-OHM) is its hydroxylated metabolite. Owing to their simil...
Metoprolol oxidation polymorphism in Brazilian elderly cardiac patients.J. Pharm. Pharmacol. 65(9) , 1347-53, (2013)
The purpose of this study was to phenotype the CYP2D6 in elderly with heart disease classified as extensive metabolizer or poor metabolizers (PM) of metoprolol, develop and validate the method of anal...
Variation of pharmacokinetics after oral administration of slow-release metoprolol tablets and pharmacogenetic considerations.Arzneimittelforschung 42(6) , 802-6, (1992)
The maximum plasma concentrations (Cmax) after oral administration of 120 mg tablets of slow-release metoprolol (CAS 37350-58-6) to 75 Japanese healthy male volunteers and 15 arrhythmic patients were ...